The Camden Study, a pregnancy cohort of 4,765 women recruited between 1985 and 2006 from one of America’s poorest cities, has found new life at Rutgers University – where it promises to unlock critical insights into maternal and child health for researchers worldwide.
Findings from a Rutgers Health study could help improve mother-infant bonding, successful breastfeeding, and mental health.
Assistant professor Pabitra Sahoo and his research team, of Rutgers University–Newark's Department of Biological Sciences, have made a breakthrough, using a peptide (or small protein fragment) to help nerve cells in both the peripheral and central nervous systems regenerate and heal.
People with disabilities have more difficulty accessing health care and more negative interactions with health care providers than people without disabilities, according to a Rutgers Health study.
Unlike white fat, which stores energy, brown fat burns calories and helps regulate body temperature.
Lo Re was president of the International Society for Pharmacoepidemiology in 2022 and is the Regional Editor for the America’s for Pharmacoepidemiology & Drug Safety, the group’s official journal.
Two Rutgers University–Newark (RU-N) researchers recently won a $250,000 grant from the Alfred P. Sloan Foundation to continue a program to increase the number of Black, Latinx and Indigenous students earning degrees in the geosciences at the Rutgers’ Newark and New Brunswick campuses, and to help them enter graduate school and/or successful careers in the field.
Rutgers Health researchers find that the diagnostic tools can be unreliable, particularly for Black patients.
Office for Research (OfR) and Rutgers-Camden leaders provided a whole day of workshops to Camden researchers on the many ways in which the OfR supports the important work being conducted at the university as it continues its path to becoming a 21st century research institution.
Victoria Abraira, an assistant professor in the Department of Cell Biology and Neuroscience in the School of Arts and Sciences at Rutgers University-New Brunswick, was named one of 126 researchers drawn from a select group of 51 institutions in the U.S. and Canada.
NanoNewron, Inc., a startup founded based on technology developed at Rutgers, The State University of New Jersey, looks to advance its potentially game changing approach towards treating Alzheimer’s Disease and other neurological conditions.
The first robotic-assisted breast reconstructions in New Jersey demonstrate the potential for technology to improve patient outcomes in many operations.